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Abstract
Patients with cardiovascular disease have increased risk of poor outcomes when coexisting illnesses are
present. Clinicians, administrators, and health services researchers utilize risk adjustment indices to stratify
patients for various outcomes. The GRACE Risk Prediction Index (GRPI) was developed to risk stratify patients
who experienced an acute coronary syndrome (ACS) event. GRPI does not account for the presence of comorbid
conditions. The objective of this study was to compare the ability of the GRPI and the Charlson Comorbidity
Index (CCI), used independently or combined, to predict mortality or secondary coronary events in patients
admitted for ACS. Data were obtained from an academic health system’s ACS registry. Outcomes included
inpatient and 6-month postdischarge mortality and occurrence of secondary cardiovascular events or revascu-
larization procedures. Logistic regression derived C statistics for CCI, GRPI, and CCI-GRPI predictive models for
each outcome. Likelihood ratio tests determined the contribution of CCI when added to GRPI models. Complete
data were available for 1202 patients. The GRPI model had the greatest C statistic when predicting inpatient
mortality (0.73); the GRPI-CCI combined model C statistic was 0.81 when predicting death during the follow-up
period; and C statistics for all 3 models were similar in predicting secondary events (0.57–0.60). The likelihood
ratio analysis demonstrated that adding CCI to GRPI models was beneficial primarily for predicting secondary
events. CCI is a useful addition to GRPI when predicting future cardiac-related events or mortality after an ACS
event. It is an acceptable alternative to the GRPI model if data to construct GRPI are not available. (Population
Health Management 2014;17:54–59)
Introduction and Background
Over 16 million people in the United States have thediagnosis of coronary artery disease.1 Coronary artery
disease is a subset of conditions of the vascular system. Car-
diovascular disease includes all diseases of the circulatory
system, including coronary artery disease, stroke, peripheral
artery disease, and diseases of the veins.1 Acute coronary
syndrome (ACS) occurs when a coronary artery becomes
acutely occluded, reducing blood flow to dependent myo-
cardium. ACS includes unstable angina and myocardial in-
farction. Over 935,000 people experience a myocardial
infarction every year.1 Patients who experience an ACS event
frequently have comorbid conditions. For example, of pa-
tients aged 65 years of age and older who presented for
emergent treatment related to an ACS event, 6.3% had 1 co-
morbid condition, 23.1% had 2 comorbidities, and 68.5% had
3 or more comorbid conditions.2
Multimorbidity, a term used to describe the coexistence of
multiple illnesses, is associated with increased mortality; 2 or
more chronic diseases result in a 2-fold or more increase in
mortality risk.3,4 Patients with cardiovascular disease have
increased risk of mortality when coexisting diabetes and
chronic kidney disease are present.5 For patients with an
acute myocardial infarction, comorbidity is also significantly
associated with inpatient mortality.6,7 Finally, a study of over
1400 patients with coronary artery disease who underwent
cardiac catheterization and were followed for 10 years
demonstrated that comorbid disease is strongly associated
with long-term survival. This particular study used the
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Charlson Comorbidity Index (CCI) to quantitate the burden
of coexisting illness.8
The CCI was developed to assess the 1-year mortality risk
in patients with comorbidities, and is widely used.9 The in-
dex consists of 10 general comorbidity categories: myocar-
dial, vascular, pulmonary, neurologic, endocrine, renal, liver,
gastrointestinal, cancer/immune, and miscellaneous. The
CCI is further divided into specific comorbidities (eg, peptic
ulcer is classified under gastrointestinal). The index is
weighted to account for the prevalence and seriousness of
the disease; for example, a myocardial infarction is given a
score of 1, whereas AIDS is weighted as a 6.9 Charlson et al
found that the index directly correlated increasing ranks of
comorbidity with greater mortality rates.9
The Global Registry of Acute Coronary Events or the
GRACE risk prediction index (GRPI) was developed as a tool
for use by clinicians to estimate the overall risk of mortality
in patients during hospitalization for an ACS event and for
the 6-month period after discharge. The index may be used
as a decision tool when developing treatment strategies. Risk
indices also may be useful for predicting hospital read-
mission rates, both to identify which patients would benefit
most from care transition interventions and to standardize
readmission risk rates for the purposes of comparisons of
hospital quality.
The GRPI is a condition-specific risk-adjustment index
that is able to predict mortality during hospitalization for the
index event, as well as at time periods of 6 months to 4 years
after the index event.10–14 The GRPI includes 9 independent
risk factor variables: age, history of myocardial infarction,
history of heart failure, increased pulse rate at presentation,
lower systolic blood pressure at presentation, elevated initial
creatinine level, elevated initial serum cardiac biomarker
levels, ST-segment depression on presenting electrocardio-
gram, and not having a percutaneous coronary intervention
performed in the hospital.12 The GRPI performed well in all
forms of ACS (C statistic of at least 0.70), proving to be a
simple, useful model to predict mortality risk and guide the
management of patients.12
Recent studies have attempted to improve the predictive
ability of the GRPI by adding biomarkers or additional
clinical measures.15–17 These studies demonstrated incre-
mental increases in predictive ability when additional in-
formation was added to the index. No studies have
attempted to improve the predictive ability of models using
the GRPI by combining with an index of comorbidity such as
the CCI. It may be reasoned that accounting for the contri-
bution of comorbid conditions that are themselves associated
with mortality would improve the predictive ability of
modeling of mortality of patients with ACS. The present
study utilized an ACS registry to assess the relative contri-
bution of the CCI when added to models that include the
GRPI in predicting mortality and secondary events or pro-
cedures. The goal of this project was to determine if the
addition of the CCI to the GRPI could improve the predictive
ability of mortality and secondary events over the GRPI.
Three end points were used for this study: inpatient mor-
tality during hospitalization for the index ACS event; out-
patient mortality within 6 to 12 months after discharge for
the index event; and occurrence of secondary events or
procedures during the follow-up period after the index
event.
Methods
Subjects in the Acute Coronary Syndrome Registry
This study used data obtained from a registry of patients
admitted to and discharged from a large university-affiliated
medical center for the treatment of ACS. The registry uses
data obtained from patients’ medical records as well as a
telephone follow-up survey or a review of medical records of
patients obtained between 6 and 12 months after discharge.
All patients aged 18 years and older admitted with the
documented diagnosis of unstable angina or acute myocar-
dial infarction between January 1999 and December 2007
were eligible for the registry. Eligibility criteria for the reg-
istry included electrocardiogram changes, elevated cardiac
enzymes, and patient-reported symptoms consistent with
cardiac ischemia within 24 h of presentation to the hospital.
Data in the registry are abstracted from the index hospitali-
zation by cardiology fellows and entered into the registry by
research assistants. Further data on follow-up events are
obtained by telephone interview or review of medical re-
cords conducted by research assistants. Mortality status at
follow-up was validated on all patients through review of
the Social Security Death Registry. The registry is approved
by the human investigations committee of the affiliated
medical school, as is the present study utilizing registry
patients.
Dependent variables
The study end points were death during hospitaliza-
tion, death during the follow-up period between discharge
and telephone follow-up, and occurrence of secondary car-
diovascular events or cardiovascular-related procedures
during the follow-up period. Cause of death was not speci-
fied. Occurrence of a secondary cardiovascular event or
cardiovascular-related medical procedure was determined
by patient self-report from the follow-up telephone survey.
Included in secondary events or procedures were hospitali-
zation for cardiac event; scheduled or unscheduled revas-
cularization procedures such as coronary artery bypass graft
or percutaneous coronary intervention; and procedures such
as stress tests.
GRACE Acute Coronary Syndrome Risk Prediction
Index
The GRACE index score was calculated for each patient in
the ACS registry. The GRACE project was a multinational
registry that contains patients who were hospitalized with
ACS.18
The GRACE database was used to create a risk prediction
model that could be used for ACS patients. This risk model is
able to predict all-cause mortality in ACS patients. As ex-
plained earlier, this model has been used in studies to predict
death and/or myocardial infarction at 6 months and long-
term mortality after the presentation of ACS.10,14 Full details
of the GRPI have been described in other reviews.12,18 The
prediction model was created using Cox proportional haz-
ards regression, which included variables such as patient
baseline characteristics, signs and symptoms at presentation,
and inhospital treatments, procedures, and complications.12
A prediction tool was developed from this data that evalu-
ates the predictor variables from the model and assigns a
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point total based on those variables for each patient. This can
then be applied to the reference plot to show the corre-
sponding risk of death using hazard ratios.
Charlson Comorbidity Index
Charlson’s method consists of a weighted index based on
the presence of comorbid conditions that predict 1-year
survival.9 The index was derived from a training population
of 559 medical inpatients at New York hospital and validated
on a testing population of 685 breast cancer patients at an-
other hospital. As a result, a list of 19 conditions, some re-
presenting 2 degrees of severity of the same condition, was
designed. Weights were assigned based on relative risk of
death, ranging from 1 to 6. The total score was the sum of the
weights, and can range from 0 to 33. Depending on the
version used, there is a list of 17 to 19 conditions. The study
demonstrated a strong association with an increase in the
10-year risk of death in a cohort of breast cancer patients9
and similar postoperative survival in patients with hyper-
tension or diabetes.19 A version of the CCI was developed by
Deyo et al and tested in Medicare beneficiaries who under-
went lumbar spine surgery. It was significantly associated
with hospital complications.20
The version of the CCI used for the present study is
known as the D’Hoore version. This version was developed
using the International Classification of Diseases, Ninth Revision
(ICD-9) codes without the Clinical Modification (CM)
codes.21 The major differences between the original CI and
the D’Hoore version is the use of only the first 3 digits of the
ICD-9 code. Three-digit ICD-9 coding is common in admin-
istrative claims data to aggregate data within conditions. For
example, no distinction is made between uncomplicated di-
abetes (ICD-9 250.0) and diabetes with complications (ICD-9
codes 250.1 through 250.9). (The D’Hoore version of the
Charlson comorbidity diseases and ICD-9 codes is available
from the authors upon request.)
Additional patient characteristics
Additional information about each patient was abstracted
from the ACS registry (ie, age, sex, race). The study was
approved by the University of Michigan Medical Institu-
tional Review Board, and patients in the study gave in-
formed consent when enrolled in the registry.
Statistical analysis
Description of the data is provided using the mean and
standard deviation for continuous variables and frequency
with percentage for categorical data. GRPI and CCI scores
were compared for each of the 3 dependent variables: death
inpatient versus alive at discharge; death in follow-up period
versus alive in follow-up period; and secondary event during
follow-up period versus no event.
The first objective of this study was to compare the pre-
dictive ability of the GRPI to that of the CCI on the outcomes
of inhospital and follow-up mortality, as well as the occur-
rence of secondary events or procedures. Logistic regression
models were run for the dichotomized outcomes (alive vs.
expired in hospital; alive vs. expired in the follow-up period;
and secondary event vs. no secondary event) for each of
the indexes along with a combined index model. Model
parameters used to describe model fit (Hosmer-Lemeshow
[H-L] chi-square test), - 2 log likelihood were derived for each
model. The H-L goodness-of-fit test was used to assess cali-
bration, where the higher the P value, the better the calibra-
tion. Model discrimination was assessed by the C statistic that
is equivalent to the area under the receiver operating char-
acteristic curve (ROC). A model with a C statistic of > 0.75 is
considered to have meaningful discriminatory ability.
The second objective of the study was to determine if
adding the CCI to the model containing the GRPI led to
improved prediction of the study end point. This was ac-
complished using the likelihood ratio test. This procedure
determines whether the addition of 1 index to a model
containing the other index improves the predictive ability
over the model that uses 1 index alone. The likelihood ratio
test is derived by calculating the difference between the - 2
log likelihood values for models that contain single indices
and a model that contains both indices (nested model). For
example, the difference between the - 2 log likelihood values
for the models of CCI alone and the CCI plus GRPI model
(nested model) is first calculated, then the P value is deter-
mined for the chi-square using 1 degree of freedom. If the
P value is < 0.05, the interpretation is that the addition of
the GRPI leads to a significant improvement in the predictive
ability of the model. This procedure was conducted for each
combination of indices and outcomes. SPSS version 18 (IBM,
Armonk, NY) and R software were used for analyses.
Results
The initial group of registry subjects included 1202 pa-
tients with complete data from the index hospitalization,
including a GRPI. These individuals also were able to have
CCI scores calculated. Characteristics of the entire study
group are listed in Table 1.
Table 2 provides the comparison of the mean index scores
based on the dichotomized dependent variables. In all
comparisons, registry patients who either died during the
inpatient or follow-up period, or who experienced a
Table 1. Characteristics of the Acute Coronary
Syndrome Registry Patients (n = 1202)
Variable
Mean (standard deviation)
or Frequency (percent) Range
Age—Years 64.2 (13.7)
18.6 to 96.5
Sex—Male 781 (65.0)
Race—White 1002 (83.4)
GRACE Score 105.7 (33.8)
20 to 211
Charlson Co-Morbidity
Score
2.3 (1.9)
0 to 11
Death in hospital
during index event
55 (4.6)
Death during follow-up
period
88 (7.7)
Secondary cardiovascular
event or related
procedure during
follow-up period
317 (38.7)
GRACE, global registry of acute coronary events.
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secondary event or procedure, had higher CCI scores indi-
cating greater comorbidity, as well as higher GRPI scores,
indicating greater risk of mortality related to the ACS event.
Multivariate logistic regression modeling results are
shown in Table 3, grouped based on the outcome assessed.
Table 4 lists the chi-square and P values for the log likelihood
ratio tests used to assess the influence of adding the CCI to
the GRPI models for each outcome. For death while an in-
patient for the index ACS event, the GRPI index model
demonstrated the best model fit. Combining the GRPI with
the CCI model had the highest value of the 3 models. The C
statistic for the GRPI model was highest, indicating greater
discriminatory ability of the GRPI over the CCI. The - 2 log
likelihood ratio P value was significant when the GRPI was
added to the CCI model, but not significant when the CCI
was added to the GRPI model. This is interpreted as the CCI
adds only slight improvement in predictive ability to the
model that already includes the GRPI.
The next outcome, death during the follow-up period, also
is described by model statistics in Table 3. The H-L chi-
square statistic was greatest for the GRPI regression model,
compared to both the CCI alone or in combination with the
Table 2. Comparison of Mean Charlson Comorbidity Index Score and GRACE Score
Mean Score (SD), n
Index Variable Alive or no secondary event Death or experienced a secondary event Sig. P value
Charlson Mortality status as
inpatient
2.23 (1.90)
n = 1147
3.45 (1.98)
n= 55
< 0.001
Mortality status during
post-hospitalization
period
2.13 (1.76)
n = 1059
4.23 (2.41)
n= 88
< 0.001
Secondary event status
during post-
hospitalization period
1.97 (1.67)
n = 503
2.61 (2.03)
n = 317
< 0.001
GRACE Mortality status as
inpatient
104.45 (33.64)
n = 1147
131.33 (27.5)
n= 55
< 0.001
Mortality status during
post-hospitalization
period
102.25 (32.96)
n = 1059
130.85 (30.6)
n= 88
< 0.001
Secondary event status
during post-
hospitalization period
100.33 (32.68)
n = 503
108.27 (32.63)
n = 317
< 0.001
*n =number of participants experiencing an outcome.
GRACE, Global Registry of Acute Coronary Events.
Table 3. Logistic Regression Models
Model -2 Log Likelihood H-L Chi-Square, P value Odds Ratio (95% CI) C statistic (95% CI)
Inpatient death CCI 430.63 8.16, 0.09 1.28 (1.14–1.43) 0.68 (0.61 to 0.75)
Inpatient death GRACE 413.21 10.41, 0.24 1.025 (1.02–1.03) 0.73 (0.67 to 0.79)
Inpatient death
combined CCI and
GRACE
408.61 8.20, 0.41 1.02 (1.01–1.03)
1.16 (1.02–1.31)
0.75
p< 0.001
Follow-up death CCI 542.48 12.72, 0.013 1.55 (1.41–1.72) 0.77 (0.72–0.82)
Follow-up death
GRACE
561.41 7.89, 0.44 1.03 (1.02–1.03) 0.74 (0.69–0.79)
Follow-up death
combined CCI and
GRACE
515.47 17.4, 0.026 1.44 (1.3–1.6)
1.02 (1.01–1.03)
0.81
p< 0.001
Postdischarge cardiac
event or procedure
CCI
1070.51 10.46, 0.03 1.21 (1.12–1.31) 0.60 (0.56–0.64)
Postdischarge cardiac
event or procedure
GRACE
1082.82 6.82, 0.56 1.01 (1.003–1.01) 0.57 (0.53–0.61)
Postdischarge cardiac
event or procedure
combined CCI and
GRACE
1066.79 4.66, 0.79 1.09 (1.02–1.16)
1.006 (1.002–1.01)
0.58
p< 0.001
CCI, Charlson Comorbidity Index; GRACE, Global Registry of Acute Coronary Events; H-L, Hosmer-Lemeshow Test.
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GRPI. The C statistic for the CCI was highest for the CCI
model, followed closely by the GRPI model C statistic. This
indicates that both indices have similar ability to discrimi-
nate the outcome of death during the follow-up period. The
- 2 log likelihood ratio test demonstrated that there was
significant improvement to each model when combined with
the other index.
The models for the outcome of experiencing a secondary
event or procedure during the follow-up period demon-
strated that the GRPI alone model as well as the combined
GRPI with CCI had relatively high P values for the H-L chi-
square test, indicating acceptable model calibration. The C
statistic for the CCI model was marginally greater than the
GRPI, both being below that important value of 0.7. The - 2
log likelihood ratio test indicated that adding the CCI to a
model containing the GRPI significantly improved model
predictive ability, while adding the GRPI to a model start-
ing with the CCI alone only marginally improved model
performance.
Discussion
Risk indices such as the GRPI are developed to assist the
clinician when determining the type and intensity of current
and near-term clinical interventions that may be necessary
for patients who have experienced a medical event. Risk-
adjustment indices also are used by health care administra-
tors to allocate resources based on patient acuity.
The GRPI needs no assistance to predict mortality of pa-
tients with ACS during the index hospitalization. The GRPI,
with a C statistic above 0.7, was greater than the CCI’s C
statistic, which was less than 0.7, while the log likelihood
ratio analysis demonstrated that adding the CCI to a model
with GRPI already included did not greatly improve its
predictive ability. The GRPI model was originally developed
to predict mortality during the inpatient stay, and is useful as
a risk stratification tool for clinicians to use to determine
therapies. Other work examining the GRPI has demonstrated
similar or higher C statistics.22
GRPI and CCI offer similar predictions of outcomes after
discharge. The C statistic for each index model was similar for
mortality after discharge as well as for occurrence of sec-
ondary events or procedures. In fact, the CCI had a greater
association with each outcome. The log likelihood ratio
analysis demonstrated that adding the CCI to models con-
taining GRPI significantly improved the predictive ability
over the GRPI alone model, while adding GRPI to models that
initially included only the CCI did not improve predictive
performance. Over the 6-month follow-up period, the CCI
was better at predicting both death and a secondary cardio-
vascular event in comparison to GRPI. This may be a function
of the important role that comorbidity plays in determining
patient outcomes, and the fact that comorbidities are not
mutually exclusive in their association with longer term out-
comes. This is not surprising given that the CCI has been well
established as an index with excellent long-term predictive
value. Charlson et al demonstrated that the model was able to
predict mortality in breast cancer patients for up to 10 years.
Furthermore, patients with a higher ranking comorbidity
exhibited a higher risk of mortality at follow-up.9
The general findings of this study are that the GRPI is
adequate to predict mortality for the inpatient index event as
well as during a period of 6 to 10 months after discharge. It
is, by itself, an effective risk adjustment for predicting sec-
ondary events after discharge. Adding the CCI to models
using the GRPI is useful to improve the prediction of out-
patient mortality or secondary events after discharge. The
CCI proved to be equally useful in predicting these outcomes
if used alone.
The important point is that the clinical data necessary to
derive an index score such as the GRPI are not always
available to the health services researcher, the population
health manager, or the clinician. The data necessary to cal-
culate the GRPI require access to the medical record for
manual extraction or extensive programming to extract from
a health system’s data warehouse. Often, however, data are
available on diagnoses for individual patients, particularly in
administrative claims data or clinical summary documents in
the medical record. Using the CCI, or a similar diagnosis-
derived index, may be useful in situations in which the
clinical data comprising the GRPI model are not available.
This study has several limitations. A retrospective analysis
of existing registry data such as this includes problems of
variability in physician documentation; specifically, omission
of diagnoses in the emergency and hospital setting that may
have led to lower than expected correlations between pre-
dicted and observed outcomes. Another limitation is that the
contribution of specific diseases within the CCI to the out-
comes was not studied. There may be a subset of conditions
within the CCI that have the greatest association with the
outcomes. In addition, using a predefined set of conditions
limits the ability to detect the association of non-included
diagnoses on the outcome of interest. There is a limitation
when using a single-value index to control for the influence
of comorbid conditions, because it does not allow the re-
searcher to directly assess the individual influence of specific
diseases that make up the index. However, if the purpose of
including a single-value index is strictly to control for po-
tential variation related to these conditions, allowing the
analyst to focus on other, hypothesized important variables,
then use of the CCI plus GRPI is appropriate.
Conclusion
The findings presented here suggest that the CCI would
be a useful addition to the GRPI when analyzing future
cardiac-related events or mortality after discharge for an
ACS event.
Table 4. -2 Log Likelihood Ratio Test
Index model description Chi-square value P value
Inpatient mortality
CCI and combined 22.013 < 0.001
GRACE and combined 4.594 0.03
Follow-up period mortality
CCI and combined 27.009 < 0.001
GRACE and combined 18.934 < 0.001
Secondary cardiovascular event or related procedure
CCI and combined 3.726 0.05
GRACE and combined 16.031 < 0.001
CCI, Charlson Comorbidity Index; GRACE, Global Registry of
Acute Coronary Events Index.
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